Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based Immunotherapy
Abstract
Dimethylsufoxide (DMSO) being universally used as a cryoprotectant in clinical adoptive cell-therapy settings to treat hematological malignancies and solid tumors is a growing concern, largely due to its broad toxicities. Its use has been associated with significant clinical side effects-cardiovascular, neurological, gastrointestinal, and allergic-in patients receiving infusions of cell-therapy products. DMSO has also been associated with...
Paper Details
Title
Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based Immunotherapy
Published Date
Aug 24, 2021
Journal
Volume
35
Issue
5
Pages
529 - 545
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History